Huimin Geng

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	8485	4324
h-endeksi	49	41
i10-endeksi	79	65

980

490

245

735

20082009201020112012201320142015201620172018201920202021202220232024202527 49 95 179 237 301 348 516 476 585 619 640 716 962 794 827 873 149

Genel erişim

Tümünü görüntüle

84 makale

8 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Christian HurtzLoma Linda Universityllu.edu üzerinde doğrulanmış e-posta adresine sahip
Randy D GascoyneProfessor of Pathology, University of British Columbiabccancer.bc.ca üzerinde doğrulanmış e-posta adresine sahip
Olivier ElementoDirector, Englander Institute for Precision Medicine, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Thomas A MilneUniversity of Oxford, Weatherall Institute of Molecular Medicineimm.ox.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Assoc. Prof. Dr. Can KüçükDepartment of Medical Biology, Faculty of Medicine, Dokuz Eylül Universitydeu.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Yanwen JiangInstructor, Weill Cornell Medical College of Cornell Universitymed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Clifford LowellProfessor, University of California, San Franciscoucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Elaine JaffeNational Cancer Institutemail.nih.gov üzerinde doğrulanmış e-posta adresine sahip
William WL ChoiHonorary Clinical Assistant Professor, The University of Hong Kongpathology.hku.hk üzerinde doğrulanmış e-posta adresine sahip
Franziska MichorAssociate Professor of Biostatistics, Harvard Universityjimmy.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Wan L. LamBC Cancer Research Centre; University of British Columbiabccrc.ca üzerinde doğrulanmış e-posta adresine sahip
Björn TitzRoche pREDroche.com üzerinde doğrulanmış e-posta adresine sahip
David W ScottClinician-Scientist, BC Cancer; Associate Professor, Department of Medicine, University of Britishbccancer.bc.ca üzerinde doğrulanmış e-posta adresine sahip
Markus RiesterNovartis Institutes for Biomedical Researchnovartis.com üzerinde doğrulanmış e-posta adresine sahip
Bhavana DaveProfessor, University of Nebraska Medical Centerunmc.edu üzerinde doğrulanmış e-posta adresine sahip
Ryan D. MorinProfessor, Simon Fraser University; Scientist at Genome Sciences Centre, BC Cancer Agencysfu.ca üzerinde doğrulanmış e-posta adresine sahip
Fabien CampagneMachine Intelligence (ML/AI) Consultantcampagne-mic.com üzerinde doğrulanmış e-posta adresine sahip
Warren SangerProfessor of Pediatrics, University of Nebraska Medical Centerunmc.edu üzerinde doğrulanmış e-posta adresine sahip
Maria E. FigueroaProfessor in Biochemistry & Molecular Biology, Sylvester Comprehensive Cancer Center, University ofmiami.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Huimin Geng

Associate Adjunct Professor, UCSF

ucsf.edu üzerinde doğrulanmış e-posta adresine sahip

Bioinformatics Genomics Epigenetics Lymphoma Leukemia


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy WWL Choi, DD Weisenburger, TC Greiner, MA Piris, AH Banham, ... Clinical cancer research 15 (17), 5494-5502, 2009	870	2009
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma J Iqbal, DD Weisenburger, TC Greiner, JM Vose, T McKeithan, C Kucuk, ... Blood, The Journal of the American Society of Hematology 115 (5), 1026-1036, 2010	434	2010
EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis I Velichutina, R Shaknovich, H Geng, NA Johnson, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 116 (24), 5247-5255, 2010	391	2010
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas Y Jiang, A Ortega-Molina, H Geng, HY Ying, K Hatzi, S Parsa, D McNally, ... Cancer discovery 7 (1), 38-53, 2017	281	2017
Metal ion-directed functional metal–phenolic materials H Geng, QZ Zhong, J Li, Z Lin, J Cui, F Caruso, J Hao Chemical Reviews 122 (13), 11432-11473, 2022	248	2022
TET1 is a tumor suppressor of hematopoietic malignancy L Cimmino, MM Dawlaty, D Ndiaye-Lobry, YS Yap, S Bakogianni, Y Yu, ... Nature immunology 16 (6), 653-662, 2015	241	2015
Metabolic gatekeeper function of B-lymphoid transcription factors LN Chan, Z Chen, D Braas, JW Lee, G Xiao, H Geng, KN Cosgun, C Hurtz, ... Nature 542 (7642), 479-483, 2017	238	2017
Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia S Swaminathan, L Klemm, E Park, E Papaemmanuil, A Ford, SM Kweon, ... Nature immunology 16 (7), 766-774, 2015	233	2015
BCL6 enables Ph⁺ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition C Duy, C Hurtz, S Shojaee, L Cerchietti, H Geng, S Swaminathan, ... Nature 473 (7347), 384-388, 2011	224	2011
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies J Iqbal, C Kucuk, RJ Deleeuw, G Srivastava, W Tam, H Geng, D Klinkebiel, ... Leukemia 23 (6), 1139-1151, 2009	218	2009
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma JL Rubenstein, H Geng, EJ Fraser, P Formaker, L Chen, J Sharma, ... Blood Advances 2 (13), 1595-1607, 2018	186	2018
DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma R Shaknovich, H Geng, NA Johnson, L Tsikitas, L Cerchietti, JM Greally, ... Blood, The Journal of the American Society of Hematology 116 (20), e81-e89, 2010	179	2010
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile K Cramer-Morales, M Nieborowska-Skorska, K Scheibner, M Padget, ... Blood, The Journal of the American Society of Hematology 122 (7), 1293-1304, 2013	175	2013
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma MG Cardenas, W Yu, W Beguelin, MR Teater, H Geng, RL Goldstein, ... The Journal of clinical investigation 126 (9), 3351-3362, 2016	168	2016
RUNX1 is a key target in t (4; 11) leukemias that contributes to gene activation through an AF4-MLL complex interaction AC Wilkinson, E Ballabio, H Geng, P North, M Tapia, J Kerry, D Biswas, ... Cell reports 3 (1), 116-127, 2013	167	2013
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia Z Chen, S Shojaee, M Buchner, H Geng, JW Lee, L Klemm, B Titz, ... Nature 521 (7552), 357-361, 2015	161	2015
MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199 JM Benito, L Godfrey, K Kojima, L Hogdal, M Wunderlich, H Geng, I Marzo, ... Cell reports 13 (12), 2715-2727, 2015	157	2015
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy YT Hsieh, EJ Gang, H Geng, E Park, S Huantes, D Chudziak, K Dauber, ... Blood, The Journal of the American Society of Hematology 121 (10), 1814-1818, 2013	141	2013
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ... PLoS genetics 9 (1), e1003137, 2013	138	2013
Erk negative feedback control enables pre-B cell transformation and represents a therapeutic target in acute lymphoblastic leukemia S Shojaee, R Caeser, M Buchner, E Park, S Swaminathan, C Hurtz, ... Cancer cell 28 (1), 114-128, 2015	136	2015

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar